Guggenheim Capital’s Chemours CC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $617K | Sell |
30,054
-17,646
| -37% | -$404K | ﹤0.01% | 1203 |
|
|
2026
Q1 | $1.05M | Sell |
47,700
-25,981
| -35% | -$452K | 0.01% | 978 |
|
|
2025
Q4 | $869K | Sell |
73,681
-5,193
| -7% | -$66.7K | 0.01% | 1012 |
|
|
2025
Q3 | $1.25M | Buy |
78,874
+127
| +0.2% | +$1.84K | 0.01% | 845 |
|
|
2025
Q2 | $902K | Buy |
78,747
+20,273
| +35% | +$228K | 0.01% | 927 |
|
|
2025
Q1 | $791K | Buy |
58,474
+14,053
| +32% | +$233K | 0.01% | 976 |
|
|
2024
Q4 | $751K | Buy |
44,421
+21,137
| +91% | +$411K | 0.01% | 1055 |
|
|
2024
Q3 | $473K | Buy |
23,284
+13,909
| +148% | +$284K | ﹤0.01% | 1427 |
|
|
2024
Q2 | $212K | Buy |
9,375
+459
| +5% | +$12K | ﹤0.01% | 1753 |
|
|
2024
Q1 | $234K | Sell |
8,916
-455
| -5% | -$13K | ﹤0.01% | 1731 |
|
|
2023
Q4 | $296K | Sell |
9,371
-481
| -5% | -$13.1K | ﹤0.01% | 1667 |
|
|
2023
Q3 | $276K | Sell |
9,852
-777
| -7% | -$26.7K | ﹤0.01% | 1653 |
|
|
2023
Q2 | $392K | Sell |
10,629
-22,978
| -68% | -$701K | ﹤0.01% | 1565 |
|
|
2023
Q1 | $1.01M | Sell |
33,607
-5,457
| -14% | -$180K | 0.01% | 1183 |
|
|
2022
Q4 | $1.2M | Buy |
39,064
+24,781
| +173% | +$744K | 0.01% | 1070 |
|
|
2022
Q3 | $352K | Sell |
14,283
-4,987
| -26% | -$165K | ﹤0.01% | 1613 |
|
|
2022
Q2 | $617K | Sell |
19,270
-8,943
| -32% | -$329K | ﹤0.01% | 1465 |
|
|
2022
Q1 | $888K | Buy |
28,213
+8,718
| +45% | +$273K | 0.01% | 1421 |
|
|
2021
Q4 | $654K | Sell |
19,495
-13,558
| -41% | -$422K | ﹤0.01% | 1556 |
|
|
2021
Q3 | $961K | Sell |
33,053
-22,433
| -40% | -$726K | 0.01% | 1439 |
|
|
2021
Q2 | $1.93M | Sell |
55,486
-9,823
| -15% | -$325K | 0.01% | 1119 |
|
|
2021
Q1 | $1.82M | Sell |
65,309
-19,610
| -23% | -$522K | 0.01% | 1080 |
|
|
2020
Q4 | $2.1M | Sell |
84,919
-27,922
| -25% | -$664K | 0.01% | 946 |
|
|
2020
Q3 | $2.36M | Buy |
112,841
+12,488
| +12% | +$241K | 0.02% | 819 |
|
|
2020
Q2 | $1.54M | Buy |
100,353
+21,762
| +28% | +$275K | 0.01% | 993 |
|
|
2020
Q1 | $697K | Buy |
78,591
+1,522
| +2% | +$21.9K | 0.01% | 1253 |
|
|
2019
Q4 | $1.39M | Sell |
77,069
-2,741
| -3% | -$45.5K | 0.01% | 1195 |
|
|
2019
Q3 | $1.19M | Buy |
79,810
+5,750
| +8% | +$93.5K | 0.01% | 1239 |
|
|
2019
Q2 | $1.78M | Buy |
74,060
+12,629
| +21% | +$372K | 0.01% | 1108 |
|
|
2019
Q1 | $2.28M | Sell |
61,431
-28,835
| -32% | -$1.05M | 0.02% | 1012 |
|
|
2018
Q4 | $2.55M | Buy |
90,266
+13,345
| +17% | +$422K | 0.02% | 920 |
|
|
2018
Q3 | $3.03M | Buy |
76,921
+50,785
| +194% | +$2.22M | 0.02% | 1009 |
|
|
2018
Q2 | $1.16M | Sell |
26,136
-217,665
| -89% | -$10.8M | 0.01% | 1538 |
|
|
2018
Q1 | $11.9M | Sell |
243,801
-4,078
| -2% | -$204K | 0.03% | 620 |
|
|
2017
Q4 | $12.4M | Buy |
247,879
+95,682
| +63% | +$5.01M | 0.03% | 625 |
|
|
2017
Q3 | $7.7M | Sell |
152,197
-2,769
| -2% | -$131K | 0.02% | 813 |
|
|
2017
Q2 | $5.88M | Sell |
154,966
-11,298
| -7% | -$446K | 0.02% | 936 |
|
|
2017
Q1 | $6.4M | Sell |
166,264
-3,653
| -2% | -$110K | 0.02% | 890 |
|
|
2016
Q4 | $3.75M | Sell |
169,917
-243,237
| -59% | -$4.99M | 0.01% | 1185 |
|
|
2016
Q3 | $6.61M | Buy |
413,154
+36,930
| +10% | +$422K | 0.02% | 861 |
|
|
2016
Q2 | $3.1M | Buy |
376,224
+154,397
| +70% | +$1.38M | 0.01% | 1278 |
|
|
2016
Q1 | $1.55M | Sell |
221,827
-2,258
| -1% | -$11.3K | ﹤0.01% | 1747 |
|
|
2015
Q4 | $1.2M | Buy |
224,085
+201,625
| +898% | +$1.29M | ﹤0.01% | 1990 |
|
|
2015
Q3 | $145K | Buy |
+22,460
| New | +$235K | ﹤0.01% | 2774 |
|
Other funds holding CC
CCPM
Guggenheim Capital's CC Position: Q2 2026 in Review
Guggenheim Capital reduced its Chemours (CC) stake by 37% in Q2 2026, selling an estimated $404K and leaving 30,054 shares worth $617K. The position accounts for ﹤0.01% of the portfolio, ranked #1203.
Guggenheim Capital first reported a position in CC in Q3 2015 and has held it in 44 quarters since. The position peaked at $12.4M in Q4 2017. 469 funds tracked by Wall St. Rank hold CC as of Q2 2026.
- Guggenheim Capital held 30,054 shares of Chemours worth $617K as of Q2 2026.
- Guggenheim Capital sold 17,646 Chemours shares in Q2 2026, an estimated $404K.
- Chemours made up ﹤0.01% of Guggenheim Capital's portfolio in Q2 2026, its #1203 holding.
- Guggenheim Capital first reported a position in Chemours in Q3 2015 and has held it in 44 quarters since.
- Guggenheim Capital's Chemours position peaked at $12.4M in Q4 2017.
- 469 funds tracked by Wall St. Rank held Chemours as of Q2 2026.
Based on Guggenheim Capital's 13F filing for Q2 2026, filed 12 Aug 2026.